Key Takeaways
- • 2023 marked the second consecutive year of decline in private equity healthcare dealmaking from its 2021 peak, driven by macroeconomic headwinds including elevated interest rates and labor shortages that constrained deal activity across the sector.
- • Add-on acquisitions to PE-backed platform companies dominated 2023 activity, representing 64 percent of all private equity-backed healthcare deals, indicating a consolidation-focused strategy within existing portfolio holdings rather than new greenfield investments.
- • Healthcare remains structurally attractive to private equity investors due to permanent demand for services, an aging population with high disease burden, and fragmented subsectors ripe for consolidation, despite near-term deal volume pressures.
- • Private equity firms continued healthcare investments throughout 2023 despite macroeconomic challenges, signaling sustained conviction in long-term sector fundamentals and the durability of healthcare services as an investment theme.
Summary
Private equity dealmaking in U.S. healthcare experienced its second consecutive year of decline in 2023 from the 2021 peak, according to analysis by the Private Equity Stakeholder Project (PESP). The slowdown reflects broader macroeconomic pressures affecting alternative asset classes, particularly elevated interest rates and labor market constraints that reduced acquisition velocity across healthcare services and related subsectors.
Despite deal volume headwinds, the composition of private equity activity shifted meaningfully in 2023. Add-on acquisitions to existing platform companies accounted for 64 percent of all private equity-backed healthcare transactions, demonstrating that firms prioritized deepening and consolidating existing holdings rather than initiating new platform acquisitions. This strategy allows investors to achieve scale and operational synergies within portfolio companies while capital deployment remains selective amid higher cost-of-capital environments.
The underlying structural appeal of healthcare private equity remains intact. The sector benefits from secular tailwinds including permanent demand for healthcare services, an aging U.S. population characterized by increasing disease burden, and highly fragmented subsectors—including outpatient care, specialty practices (eye care, gastroenterology, cardiology, oncology), dental, medtech, behavioral health, home health, and fertility services—that present consolidation opportunities. These fundamentals continue to attract private equity capital despite near-term cyclical pressures.
The PESP analysis covered a comprehensive range of healthcare segments in 2023, tracking acquisitions across physician practices, facility-based care, and ancillary services. The report's detailed sector breakdowns provide institutional investors with granular visibility into where PE capital concentrated amid the broader dealmaking slowdown, offering insights into which subsectors retained resilience and investor conviction during a challenging macroeconomic period.
Despite deal volume headwinds, the composition of private equity activity shifted meaningfully in 2023. Add-on acquisitions to existing platform companies accounted for 64 percent of all private equity-backed healthcare transactions, demonstrating that firms prioritized deepening and consolidating existing holdings rather than initiating new platform acquisitions. This strategy allows investors to achieve scale and operational synergies within portfolio companies while capital deployment remains selective amid higher cost-of-capital environments.
The underlying structural appeal of healthcare private equity remains intact. The sector benefits from secular tailwinds including permanent demand for healthcare services, an aging U.S. population characterized by increasing disease burden, and highly fragmented subsectors—including outpatient care, specialty practices (eye care, gastroenterology, cardiology, oncology), dental, medtech, behavioral health, home health, and fertility services—that present consolidation opportunities. These fundamentals continue to attract private equity capital despite near-term cyclical pressures.
The PESP analysis covered a comprehensive range of healthcare segments in 2023, tracking acquisitions across physician practices, facility-based care, and ancillary services. The report's detailed sector breakdowns provide institutional investors with granular visibility into where PE capital concentrated amid the broader dealmaking slowdown, offering insights into which subsectors retained resilience and investor conviction during a challenging macroeconomic period.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.